February freeze hits biotech as companies cut staff, thin pipelines and merge to survive
Biotech market conditions have been frigid for over a year now. Company after company has laid off staffers, thinned out pipelines, and a number …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
